Navigation Links
Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
Date:10/30/2012

INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president of enterprise risk management effective Jan. 1, 2013. Barnes will replace Anne Nobles, who will retire at the end of the year.

Barnes, vice president and deputy general counsel, is currently responsible for litigation, compliance and specialty legal areas, including regulatory and human resources. In her new role, Barnes will report to John Lechleiter, Ph.D., chairman, president and CEO, and will serve on the company's executive committee.

"Melissa's legal background and extensive experience at Lilly make her the right person to assume this important role within our company," said Lechleiter.  "Lilly is committed to conducting our business with the highest level of integrity and in full compliance with the laws and regulations that govern our operations. Having someone with Melissa's qualifications lead our ethics and compliance organization is evidence of this commitment."  

Barnes is a graduate of Harvard Law School. She joined the company in 1994 and has served in a number of legal and business positions at Lilly, specializing in legal work related to compliance, litigation, human resources, regulatory, business management strategy, and global marketing and sales.

Nobles joined Lilly in 1990 and has served in various leadership positions, including vice president of corporate affairs.  She became Lilly's chief compliance officer in 2007 and has served on the company's executive committee since 2009.

"Anne has provided critical leadership at a very important time for our company," said Lechleiter. "Her contributions have been instrumental in building a comprehensive company-wide ethics and compliance program. She has worked closely w
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
2. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
3. Lilly Announces Results From Lung Cancer Study
4. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
5. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
6. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
7. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
8. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
9. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
10. Lilly Reports Second-Quarter 2012 Results, Raises 2012 EPS Guidance
11. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... AVIV, Israel , Sept. 23, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... therapy for the treatment of liver diseases and ... and Drug Administration, or the FDA, approved its ... candidate, aramchol, for the treatment of Non-Alcoholic Steato-Hepatitis, ...
(Date:9/23/2014)...  Vesselon, Inc. today announced the appointment of Jurgen ... 15, 2014. Dr. Raths, appointment follows Vesselon,s engagement with ... market a private preferred Series A round to facilitate ... "Jurgen,s deep experience across multiple functional areas of ... Vesselon as we develop our device that can be ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 2Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH 3Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3
... (NYSE: DGX ), the world,s leading provider of ... of Directors declared a quarterly cash dividend of $0.17 per ... of Quest Diagnostics common stock on April 3, 2012. ... is the world,s leading provider of diagnostic testing, information and ...
... For the first time, consumers shopping for over-the-counter ... system that appears on the skin, affecting as ... joint and tendon disease—will find a National Psoriasis ... experts deem effective in relieving disease symptoms. Learn ...
Cached Medicine Technology:National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 2National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 3
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 23, 2014 What information do ... National Quality Forum (NQF) released a report ( ... and an infographic ( http://bit.ly/1tX3lzA ) resulting from ... healthcare, how patients define affordability, and what information ... the best possible healthcare at the lowest possible ...
(Date:9/23/2014)... recent Oregon survey about an exercise DVD that adds ... of elementary school students found it had a high ... offered clear advantages for overly sedentary educational programs. , ... by the Healthy Youth Program of the Linus Pauling ... , Brain Breaks leads children in 5-7 minute segments ...
(Date:9/23/2014)... California (PRWEB) September 23, 2014 ... Oracle services market. Included are Oracle Managed ... Augmentation. Trevera supports all versions of Oracle E-Business ... point releases. , Trevera has announced a ... organizations that need help with their software technology ...
(Date:9/23/2014)... September 23, 2014 Risperdal lawsuits ( ... the country, Bernstein Liebhard LLP reports. According to an ... Florida on September 19th, the Court has dismissed fraud ... in that jurisdiction on behalf of a man who ... due to his use of Risperdal. In dismissing the ...
Breaking Medicine News(10 mins):Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... be the greatest advance in waking up since coffee, ... wake up,in the morning feeling refreshed and ready to go, ... performance to spousal,relations and even driving ability. Fortunately, a unique ... a pill you take before,bedtime that will help you to ...
... specialty bio-therapeutics company developing high-value human,therapeutic proteins for commercialization, will hold its Annual ... Wednesday, April 9, 2008, Time: ... The National Club ... Toronto, Ontario Mr. ...
... look in your,medicine cabinet -- do you spot ... the nation,s dramatic increase in irresponsible,prescription drug use? ... 71 percent of prescription pain medication abusers,obtained the ... 13-year-olds,prescription drug abuse actually exceeds marijuana use., ...
... Awareness ... Month, PRINCETON, N.J., April 8, ... U.S. raising,awareness regarding the poor state of sexual health in America and urging,Americans ... and the Evolve tour is designed to address this head on by,inspiring a ...
... The appearance of a cold sore is,a sign that ... serious,illnesses emerge, according to John Sherman, ND, noted naturopathic,physician ... between 80% and 90% of the adult population have ... to Dr. Sherman, who,is the author of The Complete ...
... Moses and his,wife Ida thought they were doing everything ... multiple medical problems, Moses had an ugly,uncomfortable sore on ... go,away., Dr. Harris Greenberger, Director of Sound Foot ... and Stamford Hospitals in,Connecticut, diagnosed it as a diabetic ...
Cached Medicine News:Health News:Tired Mother Invents Pill to Wake You Up On Time 2Health News:Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure 2Health News:Prescription Drug Abuse Threatens Availability of Pain Medication 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 3Health News:A Cold Sore Is Often A Warning Sign of Deeper Health Issues, Expert Says 2Health News:Living Cell Treatment Heals Diabetic Foot Sores Fast 2
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: